Copyright: ©Author(s) 2026.
World J Orthop. Oct 18, 2026; 17(10): 124852
Published online Oct 18, 2026. doi: 10.5312/wjo.124852
Published online Oct 18, 2026. doi: 10.5312/wjo.124852
Table 1 Characteristics of included studies, mean ± SD
| Ref. | Country | Study design | Total | Sample sizes (case/control) | Sex (men/women) | Age (years) | BMI | Surgery | Study period (years) | Follow-up | Timing of use | Hormone type | ||
| HRT | Non-HRT | HRT | Non-HRT | |||||||||||
| Ayala-Ortiz et al[21] | United States | Retrospective cohort study | 34911 | 1711/33200 | 1359/352 | 12732/20468 | NR | NR | NR | TKA | From 2015 to 2022 | 3 years | At least 3 months preoperatively | TRT |
| Prieto-Alhambra et al[22] | United Kingdom | Retrospective cohort study | 10800 | 2700/8100 (only women) | 2700 | 8100 | 64.5 ± 7.7 | 64.8 ± 8.4 | 28.4/28.5 | THA and TKA | From 1986 to 2006 | 3.3 years | At least 6 and 12 months preoperatively/postoperatively | ERT |
| Hurbanek et al[23] | United States | Case-control study | 318 | 108/210 (only women) | 108 | 210 | 67 | 74 | 29/29 | THA and TKA | From 1997 to 2002 | NR | discontinued on the day of surgery or within 2 weeks preoperatively | ERT |
| Su et al[24] | United States | Retrospective cohort study | 43997 | 2285/41712 (only men) | 2285 | 41712 | 61.7 ± 9.4 | 66.2 ± 9.6 | NR | TSA | From 2010 to 2020 | 2 years | Within 6 and 12 months preoperatively | TRT |
| Parmar et al[25] | United States | Retrospective cohort study | 3812 | 1906/1906 | 1706/200 | 1706/200 | 68.66 | 68.73 | NR | TSA | From 2010 to 2022 | 2 years | Within 90 days postoperatively | TRT |
| Corban et al[26] | United States | Retrospective cohort study | 1443 | 481/962 | 481 | 962 | 60.6 | 60.5 | NR | TSA | From 2017 to 2021 | Up to a maximum of 3 years or until December 31, 2022 | Within 12 months preoperatively | TRT |
| White et al[27] | United States | Retrospective cohort study | 2738 | 1369/1369 | 668/701 | 652/717 | 68.3 ± 10.3 | 68.2 ± 10.4 | 31.2 ± 7.1/31.15 ± 6.7 | TSA | Surgery before 2020 | 5 years | within 1 year preoperatively | TRT |
| Omurzakov et al[28] | United States | Retrospective cohort study | 291517 | 6911/284606 | 2877/4034 | 102203/182403 | 67 ± 9.8 | 66 ± 10.7 | NR | TKA | Surgery before 2020 | 5 years | within 1 year preoperatively | TRT |
| Ni et al[29], THA | United States | Retrospective cohort study | 2888 | 1444/1444 | 1330/114 | 1330/114 | 61 | 61 | NR | THA | From 2005 to 2025 | 3 months | within 3 months postoperatively | TRT |
| Ni et al[29], TKA | United States | Retrospective cohort study | 3990 | 1995/1995 | 1853/142 | 1853/142 | 64 | 64 | NR | TKA | From 2005 to 2025 | 3 months | within 3 months postoperatively | TRT |
| Mousavi et al[30] | United States | Retrospective cohort study | 3558 | 1779/1779 (only women) | 1779 | 1779 | 70.2 ± 8.3 | 70.4 ± 8.3 | NR | TSA | From 2004 to 2024 | NR | At least 1-5 years preoperatively | ERT |
| Jing et al[31] | United States | Retrospective cohort study | 440 | 146/294 (only men) | 146 | 294 | NR | NR | NR | THA | NR | 90 days | Within 3 months preoperatively | TRT |
| Coden et al[18] | United States | Retrospective cohort study | 35299 | 3209/32090 (only men) | 3209 | 32090 | NR | NR | NR | TKA | NR | 1.9 years | Within 1 year preoperatively | TRT |
| Collins et al[32], THA-TRT | United States | Retrospective cohort study | 33423 | 6725/26698 | 6725 | 26698 | 61.7 ± 8.6 | 61.9 ± 8.5 | NR | THA | From 2010 to 2021 | 2 years | Within 6 months preoperatively and 6 months postoperatively | TRT |
| Collins et al[32], TKA-TRT | United States | Retrospective cohort study | 71292 | 14290/57002 (only men) | 14290 | 57002 | 62.6 ± 8.0 | 62.6 ± 8.0 | NR | TKA | From 2010 to 2021 | 2 years | Within 6 months preoperatively and 6 months postoperatively | TRT |
| Collins et al[32], THA-ERT | United States | Retrospective cohort study | 31429 | 6302/25127 (only women) | 6302 | 25127 | 66.6 ± 7.8 | 66.6 ± 7.7 | NR | THA | From 2010 to 2021 | 2 years | Within 6 months preoperatively and 6 months postoperatively | ERT |
| Collins et al[32], TKA-ERT | United States | Retrospective cohort study | 82477 | 16525/65952 (only women) | 16525 | 65952 | 65.5 ± 8.0 | 62.6 ± 8.0 | NR | TKA | From 2010 to 2021 | 2 years | Within 6 months preoperatively and 6 months postoperatively | ERT |
| Zhao et al[33], THA | United States | Retrospective cohort study | 10275 | 3425/6850 (only women) | 3425 | 6850 | 62 | 63 | NR | THA | From 2015 to 2020 | 90 days | Within 90 days preoperatively and 90 days postoperatively | ERT |
| Zhao et al[33], TKA | United States | Retrospective cohort study | 22227 | 7409/14818 (only women) | 7409 | 14818 | 62 | 63 | NR | TKA | From 2015 to 2020 | 90 days | Within 90 days preoperatively and 90 days postoperatively | ERT |
| McCormick et al[17] | United States | Retrospective cohort study | 43296 | 3936/39360 (only women) | 3936 | 39360 | NR | NR | NR | THA | NR | NR | Within 12 months preoperatively | ERT |
- Citation: Huang XC, Duan ZK, Zhang YJ, Huang HJ, Ma M, Tian C, Liu JM, Geng B. Associations of estrogen vs testosterone replacement therapy with complications after total joint arthroplasty: A systematic review. World J Orthop 2026; 17(10): 124852
- URL: https://www.wjgnet.com/2218-5836/full/v17/i10/124852.htm
- DOI: https://dx.doi.org/10.5312/wjo.124852